Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-29,863
Closed -$899K 915
2020
Q4
$899K Buy
+29,863
New +$881K 0.01% 515
2018
Q4
Sell
-8,973
Closed -$279K 1263
2018
Q3
$279K Hold
8,973
﹤0.01% 1064
2018
Q2
$273K Sell
8,973
-31,405
-78% -$899K ﹤0.01% 915
2018
Q1
$1.12M Buy
+40,378
New +$1.09M 0.01% 592
2016
Q1
Sell
-244,789
Closed -$4.85M 1001
2015
Q4
$4.85M Hold
244,789
0.04% 228
2015
Q3
$5.19M Buy
244,789
+4,907
+2% +$110K 0.05% 222
2015
Q2
$5.38M Buy
239,882
+1,262
+0.5% +$30.2K 0.05% 217
2015
Q1
$5.72M Buy
238,620
+23,133
+11% +$573K 0.05% 212
2014
Q4
$5.7M Buy
215,487
+167,819
+352% +$4.31M 0.07% 187
2014
Q3
$1.16M Buy
+47,668
New +$1.12M 0.02% 504

Other funds holding EXC

HBK Investments's EXC Position: Q4 2019 in Review

HBK Investments sold out of Exelon (EXC) in Q4 2019, closing a stake of 6,676 shares — an estimated $230K sold.

HBK Investments first reported a position in EXC in Q3 2015 and held it in 15 quarters. The position peaked at $32.4M in Q1 2018. 970 funds tracked by Wall St. Rank hold EXC as of Q4 2019.

  • HBK Investments reported no remaining Exelon position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 6,676 Exelon shares in Q4 2019, an estimated $230K.
  • HBK Investments first reported a position in Exelon in Q3 2015 and held it in 15 quarters.
  • HBK Investments's Exelon position peaked at $32.4M in Q1 2018.
  • 970 funds tracked by Wall St. Rank held Exelon as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.